Clinical Trials Directory

Trials / Sponsors / Rottapharm

Rottapharm

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnRandomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients
Hepatitis C, Chronic
Phase 2 / Phase 32013-08-01
CompletedMetabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome
Metabolic Syndrome, Insulin-resistance, Left Ventricular Hypertrophy
N/A2013-04-01
UnknownEstromineral Serena Plus and Symptomatic Menopause
Menopause
N/A2012-11-01
TerminatedEffect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients
Hepatitis C Virus Recurrence
Phase 22011-08-01
TerminatedLegalon SIL for the Treatment of HCV Recurrence in Liver Transplanted Patients
HCV Recurrence After Liver Transplantation
Phase 22010-09-01
CompletedArmolipid Plus and Metabolic Syndrome
Metabolic Syndrome
N/A2009-09-01
CompletedDARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritabl
Irritable Bowel Syndrome
Phase 32003-07-01
CompletedGlucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoar
Knee Osteoarthritis
Phase 32000-05-01